{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_period = \"second_quarter\", filing_year = 2023 and issue_code = \"MED\" sorted by filing_year descending", "rows": [[2957577, "7b178cfd-76ff-4ab0-bfa0-f3bee1a34931", "2T", "PARDES BIOSCIENCES, INC.", 401106493, "PARDES BIOSCIENCES, INC.", 2023, "second_quarter", "MED", "NIH funding for clinical trials", "Natl Institutes of Health (NIH)", null, 120000, 0, 1, "2023-04-12T10:26:43-04:00"], [2997804, "b8cd1bc0-6e62-45e0-a693-8fcae22ff5e8", "Q2", "INTERNATIONAL CHIROPRACTORS ASSOCIATION", 401105988, "INTERNATIONAL CHIROPRACTORS ASSOCIATION", 2023, "second_quarter", "MED", "The importance in increasing research resources to both chiropractic institutions, practice-based researchers, and non profits involved in advancing research.", "HOUSE OF REPRESENTATIVES,SENATE", null, 5500, 0, 0, "2023-06-13T11:00:41-04:00"], [2998233, "94d69b50-8282-418d-a8c8-7637a8fc839a", "Q2", "AUBURN HEALTH STRATEGIES, LLC", 292697, "AMERICAN PROFICIENCY INSTITUTE", 2023, "second_quarter", "MED", "proficiency testing for clinical laboratories", "Health & Human Services, Dept of (HHS)", null, null, 0, 0, "2023-06-30T17:58:58-04:00"], [2998256, "29b3d67d-bf04-4a3e-9bb9-c2393db0dc51", "Q2", "FRANCIS EDWARD & CRONIN, INC.", 311314, "CURE ALZHEIMER'S FUND", 2023, "second_quarter", "MED", "Legislation related to Alzheimer's disease research", "Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 20000, null, 0, 0, "2023-07-01T14:00:03-04:00"], [2998257, "5bdc849f-f4c5-496c-9817-74dd7acf5bfd", "Q2", "FRANCIS EDWARD & CRONIN, INC.", 311314, "PATH DECISION SUPPORT SOFTWARE, LLC", 2023, "second_quarter", "MED", "Legislation related to Diabetes Treament", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-07-01T14:02:29-04:00"], [2998388, "824cfa81-91ba-4bce-be6d-d59d66b25373", "Q2", "OCAL LOBBYING GROUP", 401106825, "SAMERA S.A.", 2023, "second_quarter", "MED", "Obtain funding for Tuberculosis monitoring.", "Natl Institutes of Health (NIH)", null, null, 0, 0, "2023-07-03T12:48:50-04:00"], [2998649, "1bd69e23-1db3-418e-ba64-bf9fb5753a73", "Q2", "MARSHALL BRACHMAN", 6848, "BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM", 2023, "second_quarter", "MED", "support funding for medical research programs", "HOUSE OF REPRESENTATIVES,SENATE", 33000, null, 0, 0, "2023-07-04T15:12:57-04:00"], [2998852, "36b08c2b-8d6d-4a81-a641-ec3f8aa057f6", "Q2", "EMERGENT STRATEGIES", 401104778, "ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION", 2023, "second_quarter", "MED", "Health tax issues and trade, Issues related to Small Business Innovation Research Program. PAHPA Reauthorization", "HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2023-07-05T10:31:33-04:00"], [2998919, "2de164b0-0392-498a-9878-a907a22d0089", "Q2", "HELIX, INC.", 401106164, "HELIX, INC.", 2023, "second_quarter", "MED", "COVID-19, Disease X and other respiratory pathogen sequencing and countermeasure development", "Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,White House Office", null, 40000, 0, 0, "2023-07-05T12:02:25-04:00"], [2998928, "6d2ad027-951e-478b-ace5-c7a3e215b58d", "2A", "FRANCIS EDWARD & CRONIN, INC.", 311314, "USAGAINSTALZHEIMER'S", 2023, "second_quarter", "MED", "Legislation related to the treatment, detection, and prevention of Alzheimer's disease", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-07-05T12:08:05-04:00"], [2998959, "5a3d7add-e5af-4943-a9ef-926090e703e6", "Q2", "MAGILL ASSOCIATES, LLC", 401103511, "THE LIVINGSTON GROUP ON BEHALF OF INNOVATIVE VACCINE TECHNOLOGIES", 2023, "second_quarter", "MED", "FY 2023 and FY 2024 appropriations for the development of a synthetic vaccine", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2023-07-05T12:51:01-04:00"], [2999139, "1dcbc5ab-ac19-4621-ad46-7057ddea9c82", "Q2", "AMERICAN COLLEGE OF CLINICAL PHARMACY", 57258, "AMERICAN COLLEGE OF CLINICAL PHARMACY", 2023, "second_quarter", "MED", "Focus interactions with the Agency for Healthcare Research and Quality (AHRQ) on the issue of Quality of Medication Therapy Management Services delivered programs authorized by the Patient Protection and Affordable Care Act (PPACA PL 111-148) and Medicare Part D plans.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 144981, 0, 0, "2023-07-06T04:40:27-04:00"], [2999267, "3e996b14-4bab-4471-b5e4-fd4431dd9f38", "Q2", "UNIVERSITY OF KENTUCKY", 400287372, "UNIVERSITY OF KENTUCKY", 2023, "second_quarter", "MED", "Barriers to research with Schedule 1 drugs NCI funding for FY24", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", null, 168800, 0, 0, "2023-07-06T11:18:33-04:00"], [2999299, "09db606d-59fe-4cca-9856-be82ae11a84b", "Q2", "REPUBLIC CONSULTING, LLC", 401016871, "IQVIA", 2023, "second_quarter", "MED", "Monitor Health Data Policy.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2023-07-06T11:42:46-04:00"], [2999427, "15afcee4-5ed3-4f1c-af56-eb0b28cc3afa", "Q2", "AMERICA'S BLOOD CENTERS", 3834, "AMERICA'S BLOOD CENTERS", 2023, "second_quarter", "MED", "Value of Blood/Reimbursement, laboratory developed tests", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 20000, 0, 0, "2023-07-06T16:07:22-04:00"], [2999445, "37b1dee4-140f-45b6-af77-352e33e0bd79", "Q2", "IMPACT MANAGEMENT GROUP", 401104137, "ARKANSAS RESEARCH ALLIANCE", 2023, "second_quarter", "MED", "On behalf of client support continued and future funding for clinical research programs in Arkansas", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-07-06T16:29:20-04:00"], [3000021, "b58eca4d-6288-4cd4-9d4a-94f7a265cf2e", "Q2", "IMPACT MANAGEMENT GROUP", 401104137, "CENTRAL ARKANSAS RADIATION THERAPY INSTITUTE, INC.", 2023, "second_quarter", "MED", "Supporting the passage of H.R. 3173 - Improving Seniors' Timely Access to Care Act of 2021", "HOUSE OF REPRESENTATIVES", null, null, 0, 0, "2023-07-08T16:48:23-04:00"], [3000191, "083f7764-0c82-4c92-bf4c-b7d9b73d0357", "Q2", "THE HARRIS FIRM", 68376, "HOLISTIC INDUSTRIES INC.", 2023, "second_quarter", "MED", "Issues pertaining to cannabis CSA scheduling.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-09T23:05:01-04:00"], [3000258, "a90b0068-f303-4c0f-8619-b2c0cc64d200", "Q2", "IPOLICY SOLUTIONS", 401105127, "ASSOCIATION FOR MOLECULAR PATHOLOGY", 2023, "second_quarter", "MED", "No bill #: Verified Innovative Testing in American Laboratories Act H.R.2369 - VALID Act of 2023", "HOUSE OF REPRESENTATIVES,SENATE", 58000, null, 0, 0, "2023-07-10T09:48:32-04:00"], [3000277, "cd957248-35fe-4fc7-822e-ebb4eb8b94b8", "Q2", "IPOLICY SOLUTIONS", 401105127, "INVITAE INC.", 2023, "second_quarter", "MED", "H.R.2369 - VALID Act of 2023 FDA Guidance, Docket No. FDA-2022-D-2983 for Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products FDA public meeting, FDA-2018-N-4002 Electronic Submission of Adverse Event Reports to FAERS Using ICH E2B(R3) Standards FDA guidance, Docket No. FDA-2023-D-0110: Clinical Trial Considerations to Support Accelerated Approval of Oncology Therapeutics", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 90000, null, 0, 0, "2023-07-10T10:03:38-04:00"], [3000525, "82de7f35-aa65-4315-9956-a12a600b7ac8", "Q2", "PENN AVENUE PARTNERS", 400918672, "CLIFFSIDE LABS, LLC", 2023, "second_quarter", "MED", "Policy and regulatory matters related to the clinical laboratory industry.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-10T16:22:01-04:00"], [3000595, "71cc7aee-eb64-4d93-ac61-ff5e4ed32406", "Q2", "MICHAEL N. MCCARTY LAW OFFICE PLLC", 401104300, "AMERICAN MEDICAL TECHNOLOGISTS", 2023, "second_quarter", "MED", "Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to \"harmonize\" clinical laboratory test results; support funding for CDC's Environmental Health Laboratory to establish pediatric reference intervals for diagnostic laboratory tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed in vitro diagnostic tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369).", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2023-07-10T18:58:53-04:00"], [3000729, "eb53e242-c743-41ac-b7b9-4a97d105fa6b", "Q2", "BEN BARNES GROUP LP", 5415, "HUNTSMAN CORPORATION", 2023, "second_quarter", "MED", "CMS Medicare", "HOUSE OF REPRESENTATIVES,SENATE", 18750, null, 0, 0, "2023-07-11T10:45:31-04:00"], [3000740, "55d3bee6-f03a-4380-8b38-9f4e1ba51dc5", "Q2", "BEN BARNES GROUP LP", 5415, "ENVIGO RMS LLC", 2023, "second_quarter", "MED", "Medical/Disease Research", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2023-07-11T10:52:52-04:00"], [3000798, "d31c4e8d-4e72-41e8-9012-cb333a55766e", "Q2", "BLUEBIRD STRATEGIES", 401105447, "MYRIAD GENETICS, INC.", 2023, "second_quarter", "MED", "Legislation to regulate clinical labs under CLIA and FDA.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2023-07-11T11:25:08-04:00"], [3000830, "7df98ad4-efd5-40db-92f4-839a0be5e70b", "Q2", "BLUEBIRD STRATEGIES", 401105447, "MYOTONIC", 2023, "second_quarter", "MED", "Increasing funding for Myotonic Dystrophy research. Fiscal Year 2024 defense appropriations legislation. Peer Review Medical Research Program and Congressional Directed Medical Research Program.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-07-11T11:43:51-04:00"], [3000938, "01f2d35f-82ca-4328-afe3-b4afae0aa504", "Q2", "COMPASS MANAGEMENT PARTNERS, INC.", 401105171, "THE LIVING LEGACY FOUNDATION OF MARYLAND", 2023, "second_quarter", "MED", "Regulations impacting accountability requirements at organ procurement organizations; organ donation matters", null, 20000, null, 0, 0, "2023-07-11T12:52:36-04:00"], [3000946, "0bbed217-c3bc-4743-91ea-6028ff349b69", "Q2", "OKLAHOMA STATE UNIVERSITY", 30165, "OKLAHOMA STATE UNIVERSITY", 2023, "second_quarter", "MED", "Graduate Medical Education funding; Teaching Health Center GME reauthorization and funding; indigenous health centers; AHEC program; MSE program; other extraneous issues as they may arise", "HOUSE OF REPRESENTATIVES,SENATE", null, 40000, 0, 0, "2023-07-11T12:59:24-04:00"], [3000952, "71303475-b0d2-4726-8fc9-7951ee941767", "Q2", "COMPASS GOVERNMENT RELATIONS PARTNERS, LLC", 401106533, "COALITION FOR INNOVATIVE LABORATORY TESTING, INC.", 2023, "second_quarter", "MED", "VALID Act of 2023 (H.R.2369); Provisions that negatively impact Clinical Laboratory Improvement Amendments (CLIA)-approved laboratory businesses", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-07-11T13:00:18-04:00"], [3001633, "4f76298d-f687-44fd-9799-2b2f62d0e4d0", "Q2", "SQUIRE PATTON BOGGS", 30906, "LA MAESTRA FOUNDATION ON BEHALF OF LA MAESTRA FAMILY CLINIC, INC.", 2023, "second_quarter", "MED", "Funding support for federally qualified health centers; reauthorization of programs", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2023-07-12T14:54:54-04:00"], [3001677, "0ccdb42f-6464-4d41-94ba-c7f6d8133f66", "Q2", "THE PETRIZZO GROUP, INC.", 305932, "DYSAUTONOMIA INTERNATIONAL", 2023, "second_quarter", "MED", "Advocate for NIH research funding for dysautonomia disorders, specifically Postural Orthostatic Tachycardia Syndrome (POTS) and funding to examine the correlation between POTS and Long COVID.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 45000, null, 0, 0, "2023-07-12T15:07:36-04:00"], [3001722, "f8055f7b-b808-4c2e-aa6e-72e2a238c297", "Q2", "THE PETRIZZO GROUP, INC.", 305932, "SEATTLE CHILDREN'S HOSPITAL RESEARCH AND FOUNDATION", 2023, "second_quarter", "MED", "Increased funding for pediatric medical research", "HOUSE OF REPRESENTATIVES,SENATE", 90000, null, 0, 0, "2023-07-12T15:19:51-04:00"], [3001832, "04a8df23-f2e5-4225-9135-b3a86f82ca61", "Q2", "SQUIRE PATTON BOGGS", 30906, "NATIONAL CANNABIS ROUNDTABLE", 2023, "second_quarter", "MED", "Reforming federal law and policy governing medical research, financial transactions, and tax deductions applicable to cannabis and allowing states and territories to set and enforce their own laws governing cannabis use.", "HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2023-07-12T16:05:06-04:00"], [3002087, "8ca63a93-103c-47a4-a06c-bc12e267d594", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "PULMONARY FIBROSIS FOUNDATION", 2023, "second_quarter", "MED", "Appropriations for research on pulmonary fibrosis", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2023-07-12T22:33:05-04:00"], [3003425, "2271a626-b306-42eb-bdd9-a75010ebcfb8", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "AMERICAN SOCIETY FOR RADIATION ONCOLOGY", 2023, "second_quarter", "MED", "Discussions regarding patient access to radiation oncology.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES", 50000, null, 0, 0, "2023-07-13T23:56:39-04:00"], [3003590, "e3432ac6-e172-490a-91eb-9ed2facd1779", "Q2", "EFB ADVOCACY, LLC", 401104430, "UNITED FOR MEDICAL RESEARCH", 2023, "second_quarter", "MED", "Funding Issues related to the National Institutes of Health", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2023-07-14T10:21:14-04:00"], [3003793, "83b739cc-4ed7-46d9-a7e0-5b2843875f00", "2T", "WILLIAMS AND JENSEN, PLLC", 41454, "ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)", 2023, "second_quarter", "MED", "Issues related to FDA regulation of medical devices, including the VALID Act.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 1, "2023-07-14T11:45:15-04:00"], [3003798, "5566ab6d-a8dc-41c5-84a5-fbce1652ec98", "2T", "WILLIAMS AND JENSEN, PLLC", 41454, "BIOBOT ANALYTICS", 2023, "second_quarter", "MED", "General education to advance policies that support wastewater-based epidemiology and wastewater surveillance data analytic technology.", "HOUSE OF REPRESENTATIVES,SENATE,White House Office", 20000, null, 0, 1, "2023-07-14T11:47:54-04:00"], [3003801, "3e7efa7a-40ea-4c4f-bc53-6d5af4292e6a", "Q2", "SPINA BIFIDA ASSOCIATION OF AMERICA", 46665, "SPINA BIFIDA ASSOCIATION OF AMERICA", 2023, "second_quarter", "MED", "Appropriations", "Centers For Disease Control & Prevention (CDC),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", null, 45536, 0, 0, "2023-07-14T11:49:20-04:00"], [3003812, "ebd85b00-efc8-41c8-a2db-5f45fea5df28", "2T", "WILLIAMS AND JENSEN, PLLC", 41454, "VERTEX PHARMACEUTICALS INCORPORATED", 2023, "second_quarter", "MED", "General education about federal policies impacting pharmaceutical development, approval, and reimbursement.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 1, "2023-07-14T11:54:22-04:00"], [3003852, "c540fae6-c0a4-4125-9fe5-8b622b1627dd", "Q2", "DREXEL UNIVERSITY", 40032273, "DREXEL UNIVERSITY", 2023, "second_quarter", "MED", "Advocacy around Medicaid reimbursements for high medicaid medical facilities", "HOUSE OF REPRESENTATIVES,SENATE", null, 81000, 0, 0, "2023-07-14T12:11:05-04:00"], [3003989, "70e89ec7-d3b6-4f72-a46a-cedfb8ef957f", "Q2", "SQUIRE PATTON BOGGS", 30906, "ALLIANCE FOR BIOSECURITY", 2023, "second_quarter", "MED", "Preparedness and response as it relates to Biosecurity.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2023-07-14T13:14:18-04:00"], [3004189, "f76bccc4-40f2-4dcf-b171-da8493d02ffe", "Q2", "WILLIAMS AND JENSEN, PLLC", 41454, "THE JED FOUNDATION", 2023, "second_quarter", "MED", "General education about mental health and suicide prevention programs.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2023-07-14T14:32:01-04:00"], [3004288, "6b9efc91-f849-49d2-a635-2870de794827", "Q2", "TIBER CREEK GROUP", 20744, "JAZZ PHARMACEUTICALS", 2023, "second_quarter", "MED", "Issues related to cannabis research; issues related to the FDA; issues related to Cannabis research at Health and Human Services.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2023-07-14T14:54:22-04:00"], [3004432, "1e1f7e06-dce3-4041-9a8b-a7ff4329cb72", "Q2", "F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES", 18411, "F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES", 2023, "second_quarter", "MED", "(MMM) Clinical Lab Fee Schedule H.R. 2377 and S. 1000. Saving Access to Laboratory Services Act (SALSA), and HR 1691 Ensuring Patient Access to Critical Breakthrough Products Act of 2023", "HOUSE OF REPRESENTATIVES,SENATE", null, 140000, 0, 0, "2023-07-14T15:50:56-04:00"], [3004681, "85a9722b-5af2-4ade-9b24-5b21382285d7", "2T", "AVENUE SOLUTIONS", 72111, "ORGANIZE", 2023, "second_quarter", "MED", "Transplantable organ procurement reform; Revisions to the Outcome Measure Requirements for Organ Procurement Organizations; Final Rule (42 CFR, Part 486)", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 1, "2023-07-14T17:26:24-04:00"], [3004719, "032e4d92-a1a8-460d-b0d8-6392d3a48224", "Q2", "STANFORD UNIVERSITY", 36492, "STANFORD UNIVERSITY", 2023, "second_quarter", "MED", "HR 2389 Resident Physician Shortage Reduction Act of 2023", "HOUSE OF REPRESENTATIVES,SENATE", null, 70000, 0, 0, "2023-07-14T17:56:59-04:00"], [3004923, "c46fc668-1b2d-4bd8-9d2e-d5ee9160cade", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "HAZELDEN BETTY FORD FOUNDATION", 2023, "second_quarter", "MED", "Educate key government stakeholders on Hazelden Betty Ford Foundation activities in support of substance use and mental health for US Service members and Veterans.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-14T21:41:22-04:00"], [3004943, "c76839ff-61e9-4202-a08e-4ce969beab55", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "ADVANCED MEDICAL TECHNOLOGY ASSOCIATION", 2023, "second_quarter", "MED", "Congressional outreach related to health care issues.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-14T22:26:17-04:00"], [3005006, "8292d3ad-8876-4fa6-a312-b2453c558b58", "Q2", "POWERS PYLES SUTTER & VERVILLE, P.C.", 32008, "PIH HEALTH FOUNDATION", 2023, "second_quarter", "MED", "Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Commerce and Justice, Science and Related Agencies Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care and Other Providers House, Senate Legislation to Fund Substance Use Disorder and Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations(E-Consults) with Related Telemedicine in Hospitals House, Senate Infrastructure Bills", "Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)", 30000, null, 0, 0, "2023-07-15T10:27:28-04:00"], [3005025, "a0d9e8bb-f964-43e4-a25a-db612fa8c75c", "Q2", "POWERS PYLES SUTTER & VERVILLE, P.C.", 32008, "CORNERSTONE CARE, INC.", 2023, "second_quarter", "MED", "FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Commerce and Justice, Science and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care and Other Providers House, Senate Legislation to Fund Substance Use Disorder and Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Infrastructure Bills", "Appalachian Regional Commission,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of", null, null, 0, 0, "2023-07-15T10:59:47-04:00"], [3005035, "810d9fbd-cdb3-4c6b-9619-5ecc5da9e6c8", "Q2", "POWERS PYLES SUTTER & VERVILLE, P.C.", 32008, "GATEWAYS HOSPITAL & MENTAL HEALTH CENTER FOUNDATION", 2023, "second_quarter", "MED", "Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Behavioral Health and Related Providers House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Care Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Infrastructure Bills", "Administration for Children & Families (ACF),Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Bureau of Justice Assistance,Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Justice, Dept of (DOJ),Office of Justice Program,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)", 20000, null, 0, 0, "2023-07-15T11:18:31-04:00"], [3005042, "1acf41d7-215d-4acd-b0fd-109a0fb14959", "Q2", "POWERS PYLES SUTTER & VERVILLE, P.C.", 32008, "HERBERT J. THOMAS MEMORIAL HOSPITAL ASSOCIATION (FKA THOMAS HEALTH)", 2023, "second_quarter", "MED", "Consolidated Appropriations Act, FY 2022, H.R. 2741, now P.L. 117-103 (FY 2022 CDS Implementation) FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Train More Primary Care, Behavioral Health and Related Providers House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Programs House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine/Telehealth in Hospitals House, Senate Infrastructure Bills", "Administration for Children & Families (ACF),Administration on Aging,Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Appalachian Regional Commission,Bureau of Labor Statistics (BLS),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Economic Development Administration,Federal Communications Commission (FCC),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Treasury, Dept of", 60000, null, 0, 0, "2023-07-15T11:41:06-04:00"], [3005066, "7421db6c-bf64-42f2-a975-23f578185d54", "Q2", "POWERS PYLES SUTTER & VERVILLE, P.C.", 32008, "MOSES WEITZMAN HEALTH SYSTEM, INC.", 2023, "second_quarter", "MED", "Consolidated Appropriations Act, 2023, H.R. 2617, now P.L. 117-328 FY 2024 House, Senate Departments of Labor, Health & Human Services, and Education and Related Agencies Appropriations Bills FY 2024 House, Senate Department of Agriculture Appropriations Bills FY 2024 House, Senate Department of Commerce and Justice, Science and Related Appropriations Bills FY 2024 House, Senate Department of Homeland Security Appropriations Bills FY 2024 House, Senate Financial Services and General Government Appropriations Bills FY 2024 House, Senate Departments of Transportation, Housing and Urban Development and Related Agencies Appropriations Bills Pursuit of Grants with Federal Agencies House, Senate Legislation to Authorize and Fund Postgraduate Nurse Practitioner Residency and Fellowship Training Programs, Postgraduate Psychiatric Fellowships, Medical Assistant Training Programs, and other Health Workforce Training Programs House, Senate Legislation to Fund Education, Training and Technical Assistance in Support of the National Health Workforce House, Senate Legislation to Fund Substance Use Disorder Prevention and Treatment House, Senate Legislation to Fund Behavioral Health Programs and Providers House, Senate Legislation to Fund FCC Broadband and Other Telehealth House, Senate Legislation to Implement Electronic Provider Consultations (E-Consults) with Related Telemedicine in Health Centers, Rural Health Clinics, and Elsewhere House, Senate Infrastructure Bills", "Administration for Children & Families (ACF),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Employment & Training Administration,Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),Veterans Affairs, Dept of (VA)", 10000, null, 0, 0, "2023-07-15T13:07:47-04:00"], [3005424, "d1ca60a5-ace2-46a9-bd4e-a3b0bf290eed", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "CHILDREN'S NATIONAL MEDICAL CENTER", 2023, "second_quarter", "MED", "Health-related issues including reimbursement, research, public-health & clinical care.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", 50000, null, 0, 0, "2023-07-15T22:49:17-04:00"], [3005431, "ca345c48-b645-4b6c-bf1a-1e46b7d2b522", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "CITY OF HOPE MEDICAL CENTER", 2023, "second_quarter", "MED", "Issues related to Medicare/Medicaid reimbursement and clinical research.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-15T22:51:18-04:00"], [3005611, "30c05f56-b360-42da-91ad-52aedff5ea03", "Q2", "FORBES-TATE", 400976792, "AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION", 2023, "second_quarter", "MED", "Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-16T11:35:37-04:00"], [3005643, "a9c2ca33-dd11-44fd-a26f-7c3705e8907b", "Q2", "FORBES-TATE", 400976792, "AMGEN USA, INC.", 2023, "second_quarter", "MED", "Issues related to Biosimilars; Issues related to drug pricing; Issues related to H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2023-07-16T11:50:28-04:00"], [3005724, "40e0438d-caea-410c-b931-a58bc358b4c6", "Q2", "FORBES-TATE", 400976792, "CALIFORNIA LIFE SCIENCES ASSOCIATION", 2023, "second_quarter", "MED", "Issues related to the life sciences industry; Issues related to drug pricing; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022(P.L. 117-169).", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2023-07-16T12:38:22-04:00"], [3005755, "26dd9370-556a-46d2-8175-d648175ba84e", "Q2", "FORBES-TATE", 400976792, "COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION", 2023, "second_quarter", "MED", "Issues pertaining to government-wide federal regulation of cannabis.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-16T13:08:52-04:00"], [3005765, "f97c0594-da97-4321-8563-744b50521a84", "Q2", "FORBES-TATE", 400976792, "CSL BEHRING", 2023, "second_quarter", "MED", "Issues related to Rx pricing.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2023-07-16T13:24:08-04:00"], [3005856, "ea8681da-5eec-43fb-a682-ffd995bfd943", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "JOHNS HOPKINS UNIVERSITY", 2023, "second_quarter", "MED", "Advised on fiscal year 2024 appropriations; Medicare reimbursement; Graduate Medical Education; higher education; price transparency; telehealth; Committee on Foreign Investment in the United States; public health; Advanced Research Projects Agency for Health; Pandemic preparedness; and clinical trial legislative and regulatory issues.", "HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 60000, null, 0, 0, "2023-07-16T15:04:16-04:00"], [3006096, "8b53e2a6-a0fe-44bf-907d-1e6769c42048", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "GINKGO BIOWORKS, INC.", 2023, "second_quarter", "MED", "Educated key government stakeholders on Ginkgo Bioworks capabilities in support of wastewater surveillance, biomanufacturing, and critical minerals.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 90000, null, 0, 0, "2023-07-16T21:53:54-04:00"], [3006098, "af368331-c80e-40f7-b932-2a9418eba074", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "ADVANCED MATERIALS AND DEVICES, INC.", 2023, "second_quarter", "MED", "Educated key government stakeholders on AMADs products applicable to the military.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2023-07-16T21:58:32-04:00"], [3006101, "60024013-751c-49b9-8680-e9b72f63f68f", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "NIRSENSE, LLC (FKA BIONICA LABS)", 2023, "second_quarter", "MED", "Educated key government stakeholders on Bionicas activities and technologies in support of the Armed Forces.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-16T22:01:54-04:00"], [3006108, "894f6bb5-6a7c-42bd-be27-7eace624b3a4", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM", 2023, "second_quarter", "MED", "Educated key government stakeholders on the Medical Technology Enterprise Consortiums activities and partnership model in support of Servicemember health and readiness.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-07-16T22:10:57-04:00"], [3006111, "19099a81-3597-44b2-8bad-a99788d07f20", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "SCIPERIO INC.", 2023, "second_quarter", "MED", "Educated key government stakeholders on Sciperio, Inc.s technology and manufacturing capabilities in support of the Department of Defense.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2023-07-16T22:14:42-04:00"], [3006113, "77412b82-a1eb-4d7c-816e-49f8455a1457", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "SMITH & NEPHEW", 2023, "second_quarter", "MED", "Educated key government stakeholders on Smith+Nephew products applicable to the military.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-07-16T22:17:07-04:00"], [3006117, "65f4ff14-79d5-4850-96a7-a7aea3a04229", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "THE GENEVA FOUNDATION", 2023, "second_quarter", "MED", "Educated key government stakeholders on The Geneva Foundations research and development activities in support of US Service members.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2023-07-16T22:21:05-04:00"], [3006119, "8ee01a89-d5b8-41af-85c2-478cb1055bee", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "THE REGENTS OF THE UNIVERSITY OF COLORADO OBO UNIVERSITY OF COLORADO ANSCHUTZ", 2023, "second_quarter", "MED", "Educated key government stakeholders on the University of Colorados medical capabilities in areas applicable to military health and readiness.", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2023-07-16T22:23:16-04:00"], [3006468, "49de3510-0c15-4147-a741-31795b807177", "Q2", "COVINGTON & BURLING LLP", 11195, "SL 2T, LLC (\"SMARTLABS\")", 2023, "second_quarter", "MED", "Education and support for policies and funding to advance turnkey, co-located, on-demand pharma grade research laboratory environments, including the House and Senate Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPA) Re-authorization and the Senate National Defense Authorization Act.", "HOUSE OF REPRESENTATIVES,SENATE", 90000, null, 0, 0, "2023-07-17T10:35:02-04:00"], [3006500, "4343c8ab-0d12-4636-80f0-7331ecd58f2a", "Q2", "STRATEGIC MARKETING INNOVATIONS", 60550, "ICHOR SCIENCES", 2023, "second_quarter", "MED", "Defense appropriations programmatic add", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2023-07-17T10:42:16-04:00"], [3006514, "34e14d33-a79b-4697-984a-03922dca1939", "Q2", "STRATEGIC MARKETING INNOVATIONS", 60550, "PSYONIC", 2023, "second_quarter", "MED", "Receive DoD medical research funding on how to best apply prosthetic to the nervous system", "Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2023-07-17T10:44:45-04:00"], [3006654, "df49ebb8-7d99-4539-9e8b-e60ac1edfbe1", "Q2", "BARKER LEAVITT, PLLC (SKA MR. JAMES C. BARKER)", 292538, "SONIC HEALTHCARE USA", 2023, "second_quarter", "MED", "Issues relating to the regulation of laboratory developed tests, the VALID Act, issues relating to PAMA (the SALSA Bill), federal policies relating to the implementation of the anti-kickback requirements of the Support for Patients and Communities Act. Physician Lab Fee schedule. Anatomic Fee Schedule and Surprise Billing. COVID Testing and billing procedures. COVID Vaccine Federal Mandate.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2023-07-17T11:26:20-04:00"], [3007136, "b1fbde76-e6c9-47d0-931f-bd817e3f829d", "Q2", "ALPINE ADVISORS", 401106595, "COALITION FOR CANNABIS POLICY, EDUCATION AND REGULATION", 2023, "second_quarter", "MED", "Issues pertaining to government-wide federal regulation of cannabis", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2023-07-17T13:47:33-04:00"], [3007521, "76a3a134-6da0-44dc-87dd-f2b77801c196", "Q2", "O'NEILL AND ASSOCIATES", 73134, "POINT32HEALTH SERVICES, INC. (FORMERLY TUFTS HEALTH PLAN)", 2023, "second_quarter", "MED", "Healthcare, Medical", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2023-07-17T15:05:08-04:00"], [3007649, "792182d8-1de6-4d73-8e21-7b44be27a39a", "Q2", "IGM BIOSCIENCES, INC.", 401106312, "IGM BIOSCIENCES, INC.", 2023, "second_quarter", "MED", "COVID Supplemental Appropriation S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to the development of an antibody therapy for COVID-19 Issues related to antimicrobial resistance (AMR) and drug development Issues related to supply chain and biopharmaceutical manufacturing FY2024 Defense Appropriations Issues related to the reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) National Biodefense Strategy and Implementation Plan H.R.3746 Fiscal Responsibility Act of 2023 H.R.4421 Preparing for All Hazards and Pathogens Reauthorization Act", "Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 230000, 0, 0, "2023-07-17T15:21:17-04:00"], [3007685, "44aa6361-a9b5-4470-940c-00fcc007ba7f", "Q2", "MCCARTHY STRATEGIC SOLUTIONS", 300936, "INOTIV, INC.", 2023, "second_quarter", "MED", "Animal research models to biopharmaceuticals, academic and government research for realizing life saving medications", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-07-17T15:29:46-04:00"], [3007694, "acd750d5-b246-4195-9172-d59157f89797", "Q2", "MCCARTHY STRATEGIC SOLUTIONS", 300936, "INOTIV, INC.", 2023, "second_quarter", "MED", "Animal research models to biopharmaceuticals, academic and government research for realizing life saving medications", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2023-07-17T15:31:06-04:00"], [3008588, "8f0eb155-ece8-4c93-a88c-1600e5808d25", "Q2", "CORNERSTONE GOVERNMENT AFFAIRS, INC.", 75557, "OU MEDICINE, INC.", 2023, "second_quarter", "MED", "Research and development of medical programs in partnership with Department of Health and Human Services and other federal agencies", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-17T21:20:45-04:00"], [3008776, "3a9109a2-3f93-4ed7-adba-8c1abba28004", "Q2", "AMERICAN SOCIETY OF ADDICTION MEDICINE", 401104864, "AMERICAN SOCIETY OF ADDICTION MEDICINE", 2023, "second_quarter", "MED", "Advocated for increased FY24 funding for HRSA's Addiction Medicine Fellowship Program ($30M) Advocated for increased FY24 funding for HRSA's Substance Use Disorder Treatment and Recovery Loan Repayment Program ($50M) Advocated for (S. 644/H.R. 1359) the Modernizing Opioid Treatment Access Act, which would allow specially registered opioid treatment program clinicians and addiction specialist physicians to prescribe methadone for OUD that can be picked up from pharmacies, subject to federal regulation or guidance on supply of methadone for unsupervised use. Advocated for S. 1165/ HR 2400- the Reentry Act, which would allow states to provide Medicaid coverage to eligible individuals up to 30 days prior to release from incarceration Advocated for HR 3074/S.971 - Due Process Continuity of Care Act, which would amend title XIX of the Social Security Act to remove the Medicaid coverage exclusion for inmates in custody pending disposition of charges, and for other purposes. Worked on draft legislation that would provide Medicare coverage for evidence-based residential SUD services Worked on draft legislation that would make permanent a state plan amendment option related to Medicaid's IMD exclusion Supported H.R.1502 - Comprehensive Opioid Recovery Centers Reauthorization Act of 2023, in its entirety Advocated for removal of in-person evaluation requirement in proposed telemedicine rules by the DEA and worked on related draft legislation Opposed proposed changes to the STAR-LRP program in S.462 - the Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023 Advocated for removal of a lifetime ban that prevents individuals convicted of a drug felony from receiving Supplemental Nutritional Assistance Program (SNAP) or Temporary Assistance for Needy Families TANF) as part of the next Farm Bill. Advocated for various substance use disorder workforce and coverage policy changes, including some of which appear in H.R. 4531, the Support for Patients and Communities Reauthorization Act. Joined coalition letter supporting S 923 - the Better Mental Health Care for Americans Act of 2023, which would expand the Mental Health Parity and Addiction Equity Act's (MHPAEA) protections to Medicare Advantage, Medicare Part D, and all of Medicaid; improve accuracy of provider directories for Medicare Advantage plans that in part combat \"ghost networks;\" address the longstanding problems on inadequate reimbursement rates for mental health/substance use disorder (MH/SUD) services in Medicare and Medicaid, including for integrated services; integrate MH/SUD care into primary care by increasing reimbursement and addressing cost-sharing; support the establishment of a Medicaid demonstration project for integrated mental health care for children in settings like schools, pediatric primary care practices, and community organizations; and require the Centers for Medicare and Medicaid Services (CMS) to align payments, measure access and quality, improve prevention services for mental health care, and bring together payers to transform behavioral health within primary care. Joined coalition letter of support of S. 1302 - the Resident Physician Shortage Reduction Act of 2023, which would expand the physician workforce and ensuring patients' access to quality care, as an estimated shortage of up to 124,000 primary care and specialty physicians in America is expected by 2034. This legislation would gradually raise the number of Medicare-supported GME positions by 2,000 for seven years, and a share such positions would be targeted to hospitals with diverse needs, including those in rural areas and that serve patients from health professional shortage areas (HPSAs). Joined coalition letter in support of Fiscal Year (FY) 2024 appropriations of $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health (NIH), and $1 million for the National Institute of Justice (NIJ) to conduct public health research into firearm morbidity and mortality prevention. Joined coalition letter in opposition to the Telehealth Benefit Expansion for Workers Act of 2023 (H.R. 824), which would have allowed employers to offer workers stand-alone telehealth benefits, potentially eroding comprehensive MH/SUD coverage and creating additional barriers for individuals to receive treatment. Joined coalition letter urging appropriators to approve the full authorized level of tobacco user fees and oppose any efforts to weaken or alter FDAs authority over tobacco products through the appropriations process. Advocated for certain annual increases for Medicare office based SUD bundled codes", "Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)", null, 50000, 0, 0, "2023-07-18T05:49:41-04:00"], [3008905, "30a90796-6597-4756-9cb9-f576680675ac", "Q2", "THE CONSILIO GROUP", 400374717, "DETECTACHEM", 2023, "second_quarter", "MED", "Colorimetric explosive and narcotic detection capabilities", "Air Force, Dept of,Defense, Dept of (DOD),Education, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,White House Office", 16500, null, 0, 0, "2023-07-18T09:17:15-04:00"], [3009396, "89f1a5b1-28f4-43fe-9adf-797efa1c703f", "Q2", "WATKINS & EAGER PLLC", 401104403, "NATIONAL FRAGILE X FOUNDATION", 2023, "second_quarter", "MED", "Assist in matters necessary for Advocacy Day planning on The Hill; Arrange meetings and appointments for NFXF officials; Work to encourage Members to act favorably on matters of interest and benefit to NFXF; Encourage Members to meet with constituents impacted by Fragile X.", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2023-07-18T10:50:51-04:00"], [3009520, "4f1d82c9-905c-47fd-bb63-3cdd3a974fb9", "Q2", "COVINGTON & BURLING LLP", 11195, "AMERICAN CLINICAL LABORATORY ASSOCIATION (ACLA)", 2023, "second_quarter", "MED", "Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation.", "Food & Drug Administration (FDA)", 30000, null, 0, 0, "2023-07-18T11:11:40-04:00"], [3009537, "f0bb824a-1886-4880-8d5b-9ad12cb37b56", "Q2", "DANA-FARBER CANCER INSTITUTE", 401106163, "DANA-FARBER CANCER INSTITUTE", 2023, "second_quarter", "MED", "Support policies to remove barriers to clinical trials, promote research generally, address issues in childhood cancer research including Gabriella Miller Kids First Research Act 2.0 (HR 3391, S 1624); Accelerating Kids Access to Care Act(HR 3089, S 1544)", "HOUSE OF REPRESENTATIVES,SENATE", null, 30156, 0, 0, "2023-07-18T11:14:08-04:00"], [3009636, "e09bcadb-8d8e-4e02-a06a-815b2f44dd7b", "Q2", "AMERICAN CLINICAL LABORATORY ASSN", 1923, "AMERICAN CLINICAL LABORATORY ASSN", 2023, "second_quarter", "MED", "Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, new test coding and pricing, definitive drug testing coding, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; reauthorization of the Pandemics and All-Hazards Preparedness Act (PL. 109-417); price transparency for clinical laboratory services, FY 2024 budget and appropriations processes Saving Access to Laboratory Services Act H.R. 2377/S. 1000, VALID Act H.R. 2369; H.R. 3791, Improving Data in Public Health Act; H.R. 3248, Diagnostic Lab Testing Transparency Act;", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", null, 633739, 0, 0, "2023-07-18T11:26:24-04:00"], [3009738, "df7f93e0-ccb1-4148-884a-3af6b18b1835", "Q2", "UNIVERSITY OF MARYLAND, BALTIMORE (UMB)", 401103161, "UNIVERSITY OF MARYLAND, BALTIMORE (UMB)", 2023, "second_quarter", "MED", "ARPA-H, budget and agency location", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 10000, 0, 0, "2023-07-18T11:38:22-04:00"], [3010067, "714c205a-b58d-45d3-83ba-335eb1167738", "Q2", "NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH", 26557, "NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH", 2023, "second_quarter", "MED", "Support funding for biomedical research", "HOUSE OF REPRESENTATIVES,SENATE", null, 30000, 0, 0, "2023-07-18T12:45:30-04:00"], [3010135, "b95e7b55-c1b7-4b0b-8a08-d2a7e46a7a1c", "Q2", "MARSHFIELD CLINIC HEALTH SYSTEM", 57830, "MARSHFIELD CLINIC HEALTH SYSTEM", 2023, "second_quarter", "MED", "research support, agriculture, farm safety, child care and agriculture communities", "HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2023-07-18T12:58:48-04:00"], [3010142, "91fcacbd-af08-41a4-9840-105eeb36852b", "Q2", "BURRELL INTERNATIONAL GROUP LLC", 401103483, "ARSENAL MEDICAL, INC.", 2023, "second_quarter", "MED", "Funding for medical devices for hemorrhage; Provisions in FY24 NDAA and FY24 Defense Appropriations", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2023-07-18T12:59:03-04:00"], [3010144, "f9651e0f-e5eb-41c4-9bd7-0d66b9b58554", "2T", "ALPINE GROUP PARTNERS, LLC.", 1171, "MINDBLOOM, INC.", 2023, "second_quarter", "MED", "Telehealth legislation and regulation Mental health policy", "HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 1, "2023-07-18T13:00:13-04:00"], [3010185, "ffbdc428-da1c-4cc1-acc4-edd978b040a8", "Q2", "FEDERAL SOLUTIONS, LLC", 311371, "MISSISSIPPI STATE UNIVERSITY", 2023, "second_quarter", "MED", "Labor/HHS/Education Appropriations: Provisions relating to disease research", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2023-07-18T13:07:55-04:00"], [3010308, "2ef09d2a-f13c-4cb4-8a86-da62759ee21a", "Q2", "DA VINCI GROUP", 11548, "KAI MEDICAL LABORATORY", 2023, "second_quarter", "MED", "Funding for Clinical Research & Diagnostics Programs", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2023-07-18T13:28:35-04:00"], [3010312, "227d9168-01f5-495c-8c21-681a39a46b32", "Q2", "DA VINCI GROUP", 11548, "KAI MEDICAL LABORATORY", 2023, "second_quarter", "MED", "Funding for Clinical Research & Diagnostics Programs", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2023-07-18T13:28:56-04:00"], [3010614, "e1b19dc6-4ede-4a64-a815-c33879628920", "Q2", "WINNING STRATEGIES WASHINGTON", 50796, "DIABETES PATIENT ADVOCACY COALITION", 2023, "second_quarter", "MED", "Issues related to treatment of diabetes and support for diabetes patients", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2023-07-18T14:18:48-04:00"], [3010695, "668732f0-71df-465b-a701-9114931f5e4b", "Q2", "IMPACT HEALTH POLICY PARTNERS", 401104696, "ABBOTT LABORATORIES", 2023, "second_quarter", "MED", "Issues related to coverage and reimbursement for durable medical equipment, medical devices, diagnostics and nutrition.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2023-07-18T14:27:29-04:00"], [3010712, "235081ea-c017-400e-88fe-4fe2a9836ef8", "Q2", "IMPACT HEALTH POLICY PARTNERS", 401104696, "CHILDREN'S HOSPITAL COLORADO", 2023, "second_quarter", "MED", "Issues related to pediatric research and children's hospital graduate medical education.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2023-07-18T14:29:43-04:00"], [3010756, "e2c54c58-aa41-44ac-abbe-18aad6d51cd6", "Q2", "IMPACT HEALTH POLICY PARTNERS", 401104696, "HACKENSACK MERIDIAN HEALTH", 2023, "second_quarter", "MED", "Issues related to research funding, including ARPA-H, NIH, organ transplants, and other matters.", "HOUSE OF REPRESENTATIVES,SENATE,White House Office", 40000, null, 0, 0, "2023-07-18T14:35:03-04:00"], [3010843, "d5728a3a-4b39-42a6-8290-a2721e5919b2", "Q2", "THE JACKSON LABORATORY", 401104723, "THE JACKSON LABORATORY", 2023, "second_quarter", "MED", "Issues related to biomedical research. Animal model use in biomedical research.", "HOUSE OF REPRESENTATIVES,Office of Science & Technology Policy (OSTP),SENATE", null, 30000, 0, 0, "2023-07-18T14:44:09-04:00"], [3010895, "44db5f05-a6b2-42f0-affe-41785d38ca8c", "Q2", "PARALYZED VETERANS OF AMERICA", 30724, "PARALYZED VETERANS OF AMERICA", 2023, "second_quarter", "MED", "Discussions: Department of Veterans Affairs, Medical Research Issues Discussions: National Institutes of Health, Medical Research Issues", "HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Veterans Affairs, Dept of (VA)", null, 90668, 0, 0, "2023-07-18T14:50:45-04:00"]], "truncated": false, "filtered_table_rows_count": 310, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_period\" = :p0 and \"filing_year\" = :p1 and \"issue_code\" = :p2 order by filing_year desc limit 101", "params": {"p0": "second_quarter", "p1": "2023", "p2": "MED"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2023&issue_code=MED", "results": [{"value": "MED", "label": "MED", "count": 310, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2023", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2023&issue_code=MED", "results": [{"value": 2023, "label": 2023, "count": 310, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&issue_code=MED", "selected": true}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2023&issue_code=MED", "results": [{"value": "second_quarter", "label": "second_quarter", "count": 310, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_year=2023&issue_code=MED", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "filing_type", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2023&issue_code=MED&_facet=filing_type"}, {"name": "is_termination", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2023&issue_code=MED&_facet=is_termination"}, {"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2023&issue_code=MED&_facet_date=received_date"}], "next": "2023,3010895", "next_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=second_quarter&filing_year=2023&issue_code=MED&_next=2023%2C3010895&_sort_desc=filing_year", "private": false, "allow_execute_sql": true, "query_ms": 2308.781513944268, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}